238 results
8-K
EX-10.1
CYCC
Cyclacel Pharmaceuticals Inc
2 May 24
Cyclacel Pharmaceuticals ANNOUNCES $8.0 MILLION PRIVATE PLACEMENT
5:00pm
is made or deemed made that has not been publicly disclosed prior to the date that this representation is made.
(j) Litigation. Except as set forth … ) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.
4.8 Indemnification of Purchasers. Subject to the provisions
424B3
CYCC
Cyclacel Pharmaceuticals Inc
14 Feb 24
Prospectus supplement
4:06pm
, our business may be harmed.
We may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual … control over financial reporting, we may not be able to accurately report our financial results in a timely manner. We may also face litigation
8-K
EX-10.2
43e2afk01y y6q
26 Dec 23
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
9:29am
8-K
l4bkdg3ysx47dyx
15 Nov 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:03pm
424B5
z5761 549wotxcl
30 Mar 22
Prospectus supplement for primary offering
5:28pm
424B5
7zdj0xqx2f4ypjmv
12 Aug 21
Prospectus supplement for primary offering
5:07pm
8-K
EX-1.1
1s0u0fgn5e3 f5bsx2
15 Mar 21
Cyclacel Pharmaceuticals Prices $12.65 Million
5:21pm
424B5
o3lybegkaumf4cs x3
12 Mar 21
Prospectus supplement for primary offering
9:41pm
424B5
lhl1bqu2g 8a6i4syx
11 Mar 21
Prospectus supplement for primary offering
4:06pm